Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | CRHBP | P24387 | 1/20 | 0.46 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.46 |
| ▸ | BCL9 | O00512 | 1/20 | 0.45 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.45 |
| ▸ | MGLL | Q99685 | 3/20 | 0.44 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.43 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.43 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.43 |
| ▸ | PRKCA | P17252 | 1/20 | 0.43 |
| ▸ | CNR1 | P21554 | 2/20 | 0.43 |
| ▸ | THRB | P10828 | 1/20 | 0.43 |
| ▸ | FAAH | O00519 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | CNR2 | P34972 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31756205 | 0.95 | MAPT (0.52) | MAPTL3MBTL1ALDH1A1TDP1CRHBP | |
| SCHEMBL22078331 | 0.89 | PRKCA (0.52) | MAPTALDH1A1TDP1PRKCEPRKCQ | |
| SCHEMBL23117093 | 0.89 | MGLL (0.52) | MAPTL3MBTL1ALDH1A1CRHBPCRHR2 | |
| SCHEMBL23117336 | 0.89 | MGLL (0.52) | MAPTL3MBTL1ALDH1A1CRHBPCRHR2 | |
| SCHEMBL17105825 | 0.89 | MGLL (0.52) | MAPTL3MBTL1ALDH1A1CRHBPCRHR2 | |
| SCHEMBL23117080 | 0.89 | MAPT (0.47) | MAPTL3MBTL1ALDH1A1TDP1CRHBP | |
| SCHEMBL31240294 | 0.89 | MAPT (0.47) | MAPTL3MBTL1ALDH1A1TDP1CRHBP | |
| SCHEMBL22078094 | 0.89 | PRKCA (0.51) | MAPTALDH1A1TDP1PRKCEPRKCQ | |
| SCHEMBL22078098 | 0.89 | PRKCA (0.51) | MAPTALDH1A1TDP1PRKCEPRKCQ | |
| SCHEMBL22077681 | 0.89 | PRKCA (0.51) | MAPTALDH1A1TDP1PRKCEPRKCQ |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260102348-A1 | COMPOUND OR SALT THEREOF AND LIPID PARTICLES | FUJIFILM CORPORATION (JP) | 2026-04-16 | — | — | US | disclosed |
| US-12508226-B2 | Lipid composition | FUJIFILM CORPORATION (JP) | 2025-12-30 | — | — | US | disclosed |
| US-12370143-B2 | Compound or salt thereof and lipid particles | FUJIFILM CORPORATION (JP) | 2025-07-29 | — | — | US | disclosed |
| EP-4328309-B1 | LIPID COMPOSITION | FUJIFILM CORP (JP) | 2025-07-02 | — | — | EP | disclosed |
| US-12285525-B2 | Compound or salt thereof and lipid particles | FUJIFILM CORPORATION (JP) | 2025-04-29 | — | — | US | disclosed |
| US-20240315970-A1 | COMPOUND OR SALT THEREOF AND LIPID PARTICLES | FUJIFILM CORPORATION (JP) | 2024-09-26 | — | — | US | disclosed |
| EP-4328309-A2 | LIPID COMPOSITION | FUJIFILM Corporation (JP) | 2024-02-28 | — | — | EP | disclosed |
| EP-4059505-B1 | LIPID COMPOSITION | FUJIFILM CORP (JP) | 2024-02-21 | — | — | EP | disclosed |
| CN-117417265-A | Lipid composition | 富士胶片株式会社 | 2024-01-19 | — | — | CN | disclosed |
| CN-112262122-B | Compound or salt and lipid particle thereof | 富士胶片株式会社 | 2023-10-13 | — | — | CN | disclosed |
| EP-3805198-B1 | COMPOUND, SALT THEREOF AND LIPID PARTICLES | FUJIFILM CORP (JP) | 2023-09-20 | — | — | EP | disclosed |
| EP-3981435-B1 | LIPID COMPOSITION | FUJIFILM CORP (JP) | 2023-08-16 | — | — | EP | disclosed |
| CN-116172975-A | Lipid particle, nucleic acid drug comprising same, and composition for nucleic acid delivery | 富士胶片株式会社 | 2023-05-30 | — | — | CN | disclosed |
| EP-4059505-A1 | LIPID COMPOSITION | FUJIFILM Corporation (JP) | 2022-09-21 | — | — | EP | disclosed |
| US-20220273817-A1 | LIPID COMPOSITION | FUJIFILM CORPORATION (JP) | 2022-09-01 | — | — | US | disclosed |
| EP-3981435-A1 | LIPID COMPOSITION | FUJIFILM Corporation (JP) | 2022-04-13 | — | — | EP | disclosed |
| US-20220096381-A1 | LIPID COMPOSITION | FUJIFILM CORPORATION (JP) | 2022-03-31 | — | — | US | disclosed |
| EP-3805198-A1 | COMPOUND, SALT THEREOF AND LIPID PARTICLES | FUJIFILM Corporation (JP) | 2021-04-14 | — | — | EP | disclosed |
| US-20210085604-A1 | COMPOUND OR SALT THEREOF AND LIPID PARTICLES | FUJIFILM CORPORATION (JP) | 2021-03-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12370143-B2 | Compound or salt thereof and lipid particles | NR1H3, NR1H2, LDLR | MAPT 4495/4885L3MBTL1 1766/4885ALDH1A1 2243/4885 |
| US-12285525-B2 | Compound or salt thereof and lipid particles | NR1H3, NR1H2, LDLR | MAPT 4495/4885L3MBTL1 1766/4885ALDH1A1 2243/4885 |
| US-20240315970-A1 | COMPOUND OR SALT THEREOF AND LIPID PARTICLES | NR1H3, NR1H2, LDLR | MAPT 4495/4885L3MBTL1 1766/4885ALDH1A1 2243/4885 |
| US-20260102348-A1 | COMPOUND OR SALT THEREOF AND LIPID PARTICLES | LDLR, NR1H3, NR1H2 | MAPT 4284/4885L3MBTL1 628/4885ALDH1A1 2418/4885 |
| US-20210085604-A1 | COMPOUND OR SALT THEREOF AND LIPID PARTICLES | NR1H3, NR1H2, LDLR | MAPT 4482/4885L3MBTL1 1762/4885ALDH1A1 2368/4885 |
| US-20220273817-A1 | LIPID COMPOSITION | NR1H3, NR1H2, NR1H4 | MAPT 4691/4885L3MBTL1 1451/4885ALDH1A1 2683/4885 |
| US-20220096381-A1 | LIPID COMPOSITION | NR1H3, NR1H4, NR1H2 | MAPT 4079/4885L3MBTL1 961/4885ALDH1A1 3097/4885 |
| US-12508226-B2 | Lipid composition | APOB, NAF1, SLC27A1 | MAPT 3749/4885L3MBTL1 460/4885ALDH1A1 2907/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.